• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严格采样对接构象揭示了 L 型氨基酸转运蛋白 1(LAT1)卤代配体的结合假说。

Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1).

机构信息

University of Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France.

Department of Pharmaceutical Chemistry, University of Vienna, Althanstrasse 14, 1090, Wien, Austria.

出版信息

Sci Rep. 2019 Oct 21;9(1):15061. doi: 10.1038/s41598-019-51455-8.

DOI:10.1038/s41598-019-51455-8
PMID:31636293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6803698/
Abstract

L-type Amino acid Transporter 1 (LAT1) plays a significant role in the growth and propagation of cancer cells by facilitating the cross-membrane transport of essential nutrients, and is an attractive drug target. Several halogen-containing L-phenylalanine-based ligands display high affinity and high selectivity for LAT1; nonetheless, their molecular mechanism of binding remains unclear. In this study, a combined in silico strategy consisting of homology modeling, molecular docking, and Quantum Mechanics-Molecular Mechanics (QM-MM) simulation was applied to elucidate the molecular basis of ligand binding in LAT1. First, a homology model of LAT1 based on the atomic structure of a prokaryotic homolog was constructed. Docking studies using a set of halogenated ligands allowed for deriving a binding hypothesis. Selected docking poses were subjected to QM-MM calculations to investigate the halogen interactions. Collectively, the results highlight the dual nature of the ligand-protein binding mode characterized by backbone hydrogen bond interactions of the amino acid moiety of the ligands and residues I63, S66, G67, F252, G255, as well as hydrophobic interactions of the ligand's side chains with residues I139, I140, F252, G255, F402, W405. QM-MM optimizations indicated that the electrostatic interactions involving halogens contribute to the binding free energy. Importantly, our results are in good agreement with the recently unraveled cryo-Electron Microscopy structures of LAT1.

摘要

L 型氨基酸转运蛋白 1(LAT1)通过促进必需营养素的跨膜转运,在癌细胞的生长和增殖中发挥重要作用,是一个有吸引力的药物靶点。一些含卤素的 L-苯丙氨酸基配体对 LAT1 表现出高亲和力和高选择性;然而,它们的结合分子机制仍不清楚。在这项研究中,应用了一种组合的计算策略,包括同源建模、分子对接和量子力学-分子力学(QM-MM)模拟,以阐明 LAT1 中配体结合的分子基础。首先,基于原核同源物的原子结构构建了 LAT1 的同源模型。使用一组卤代配体进行对接研究,得出了结合假设。选择的对接构象进行 QM-MM 计算,以研究卤素相互作用。总的来说,结果强调了配体-蛋白结合模式的双重性质,其特征是配体的氨基酸部分与残基 I63、S66、G67、F252、G255 之间的骨架氢键相互作用,以及配体侧链与残基 I139、I140、F252、G255、F402、W405 之间的疏水相互作用。QM-MM 优化表明,涉及卤素的静电相互作用有助于结合自由能。重要的是,我们的结果与最近揭示的 LAT1 低温电子显微镜结构非常吻合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/977c00ce45b3/41598_2019_51455_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/1055a4b4fe71/41598_2019_51455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/9cb256ca44a6/41598_2019_51455_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/897cfe0c2dc7/41598_2019_51455_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/8bb3e5180109/41598_2019_51455_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/f3cb4db19507/41598_2019_51455_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/b5de5a16ee36/41598_2019_51455_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/6b43baec5b69/41598_2019_51455_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/bdd2a44a4d2f/41598_2019_51455_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/735b6f57d38d/41598_2019_51455_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/1995b2d03b17/41598_2019_51455_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/11501d35684d/41598_2019_51455_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/977c00ce45b3/41598_2019_51455_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/1055a4b4fe71/41598_2019_51455_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/9cb256ca44a6/41598_2019_51455_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/897cfe0c2dc7/41598_2019_51455_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/8bb3e5180109/41598_2019_51455_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/f3cb4db19507/41598_2019_51455_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/b5de5a16ee36/41598_2019_51455_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/6b43baec5b69/41598_2019_51455_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/bdd2a44a4d2f/41598_2019_51455_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/735b6f57d38d/41598_2019_51455_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/1995b2d03b17/41598_2019_51455_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/11501d35684d/41598_2019_51455_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d551/6803698/977c00ce45b3/41598_2019_51455_Fig12_HTML.jpg

相似文献

1
Rigorous sampling of docking poses unveils binding hypothesis for the halogenated ligands of L-type Amino acid Transporter 1 (LAT1).严格采样对接构象揭示了 L 型氨基酸转运蛋白 1(LAT1)卤代配体的结合假说。
Sci Rep. 2019 Oct 21;9(1):15061. doi: 10.1038/s41598-019-51455-8.
2
Insights into the Structure, Function, and Ligand Discovery of the Large Neutral Amino Acid Transporter 1, LAT1.解析大中性氨基酸转运蛋白 1(LAT1)的结构、功能和配体发现。
Int J Mol Sci. 2018 Apr 24;19(5):1278. doi: 10.3390/ijms19051278.
3
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).重新评估 L 型氨基酸转运体(LAT1)的底物特异性。
J Med Chem. 2018 Aug 23;61(16):7358-7373. doi: 10.1021/acs.jmedchem.8b01007. Epub 2018 Aug 10.
4
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods.基于结构的方法发现大型中性氨基酸转运蛋白 1(LAT1)的有效抑制剂。
Int J Mol Sci. 2018 Dec 21;20(1):27. doi: 10.3390/ijms20010027.
5
Molecular characteristics supporting l-Type amino acid transporter 1 (LAT1)-mediated translocation.支持溶质载体家族 7 成员 11(LAT1)介导转运的分子特征。
Bioorg Chem. 2021 Jul;112:104921. doi: 10.1016/j.bioorg.2021.104921. Epub 2021 Apr 22.
6
Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.突变和配体对 l-精氨酸/胍丁胺反向转运蛋白 AdiC 热稳定性的影响及对人 l 型氨基酸转运蛋白配体结合的推断。
Int J Mol Sci. 2018 Mar 20;19(3):918. doi: 10.3390/ijms19030918.
7
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands.比较研究配体对 l 型氨基酸转运蛋白 1(LAT1)利用的实验策略。
Molecules. 2021 Dec 22;27(1):37. doi: 10.3390/molecules27010037.
8
Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake.用于选择性和高效的 l 型氨基酸转运体 1(LAT1)介导的细胞摄取的结构特性。
Int J Pharm. 2018 Jun 10;544(1):91-99. doi: 10.1016/j.ijpharm.2018.04.025. Epub 2018 Apr 15.
9
Structure-activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion.基于药效团模型和大鼠脑原位灌注的与大中性氨基酸转运体1(LAT1)结合的化合物的构效关系研究
Eur J Pharm Sci. 2013 Feb 14;48(3):523-31. doi: 10.1016/j.ejps.2012.11.014. Epub 2012 Dec 8.
10
Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.人源 LAT1-4F2hc 异型氨基酸转运体复合物的结构。
Nature. 2019 Apr;568(7750):127-130. doi: 10.1038/s41586-019-1011-z. Epub 2019 Mar 13.

引用本文的文献

1
Insight into telomere regulation: road to discovery and intervention in plasma drug-protein targets.深入了解端粒调控:血浆药物-蛋白质靶点的发现与干预之路。
BMC Genomics. 2024 Mar 2;25(1):231. doi: 10.1186/s12864-024-10116-5.
2
Docking-Based Prediction of Peptide Binding to MHC Proteins.基于对接的多肽与 MHC 蛋白结合预测。
Methods Mol Biol. 2023;2673:237-249. doi: 10.1007/978-1-0716-3239-0_17.
3
In Vitro, In Vivo, and In Silico Analyses of Molecular Anti-Pigmentation Mechanisms of Selected Thai Rejuvenating Remedy and Bioactive Metabolites.

本文引用的文献

1
Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.冷冻电镜结构解析人 L 型氨基酸转运蛋白 1 与糖蛋白 CD98hc 的复合物
Nat Struct Mol Biol. 2019 Jun;26(6):510-517. doi: 10.1038/s41594-019-0237-7. Epub 2019 Jun 3.
2
Halogens in Protein-Ligand Binding Mechanism: A Structural Perspective.卤族元素在蛋白-配体结合机制中的作用:结构视角
J Med Chem. 2019 Nov 14;62(21):9341-9356. doi: 10.1021/acs.jmedchem.8b01453. Epub 2019 May 28.
3
The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
在体、体内和计算机模拟分析泰国 rejuvenating 疗法和生物活性代谢物的分子抗色素沉着机制。
Molecules. 2023 Jan 18;28(3):958. doi: 10.3390/molecules28030958.
4
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning.利用基于结构和基于配体的分子建模以及机器学习发现新型强效赖氨酸特异性组蛋白去甲基化酶-1(LSD-1)抑制剂
RSC Adv. 2022 Dec 15;12(55):35873-35895. doi: 10.1039/d2ra05102h. eCollection 2022 Dec 12.
5
The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.人 LAT1-4F2hc(SLC7A5-SLC3A2)转运体复合物:生理和病理生理学意义。
Basic Clin Pharmacol Toxicol. 2023 Nov;133(5):459-472. doi: 10.1111/bcpt.13821. Epub 2022 Dec 13.
6
Describing inhibitor specificity for the amino acid transporter LAT1 from metainference simulations.基于元推断模拟描述氨基酸转运蛋白 LAT1 的抑制剂特异性。
Biophys J. 2022 Dec 6;121(23):4476-4491. doi: 10.1016/j.bpj.2022.11.001. Epub 2022 Nov 11.
7
Homology Modeling and Molecular Docking Approaches for the Proposal of Novel Insecticides against the African Malaria Mosquito ().同源建模和分子对接方法在新型杀虫剂针对非洲疟疾蚊子()的建议中的应用。
Molecules. 2022 Jun 15;27(12):3846. doi: 10.3390/molecules27123846.
8
Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.人LAT1-4F2hc氨基酸转运体的底物转运及抑制机制
Cell Discov. 2021 Mar 23;7(1):16. doi: 10.1038/s41421-021-00247-4.
9
Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABA Receptor by Molecular Modeling.通过分子建模揭示吡唑并喹啉酮在GABA受体细胞外α1+/β3-界面识别的分子基础
Front Pharmacol. 2020 Sep 11;11:561834. doi: 10.3389/fphar.2020.561834. eCollection 2020.
10
ATP modulates SLC7A5 (LAT1) synergistically with cholesterol.三磷酸腺苷与胆固醇协同调节溶质载体家族 7 成员 5(LAT1)。
Sci Rep. 2020 Oct 7;10(1):16738. doi: 10.1038/s41598-020-73757-y.
L 型氨基酸转运蛋白 LAT1:癌症治疗的新兴靶点
Int J Mol Sci. 2019 May 16;20(10):2428. doi: 10.3390/ijms20102428.
4
Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.人源 LAT1-4F2hc 异型氨基酸转运体复合物的结构。
Nature. 2019 Apr;568(7750):127-130. doi: 10.1038/s41586-019-1011-z. Epub 2019 Mar 13.
5
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.新型氟乙基苯丙氨酸类似物作为潜在的 LAT1 靶向脑胶质瘤正电子发射断层扫描(PET)示踪剂。
Sci Rep. 2019 Feb 27;9(1):2878. doi: 10.1038/s41598-019-40013-x.
6
Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods.基于结构的方法发现大型中性氨基酸转运蛋白 1(LAT1)的有效抑制剂。
Int J Mol Sci. 2018 Dec 21;20(1):27. doi: 10.3390/ijms20010027.
7
The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model.LAT1 抑制剂 JPH203 可降低完全免疫活性小鼠模型中甲状腺癌的生长。
J Exp Clin Cancer Res. 2018 Sep 21;37(1):234. doi: 10.1186/s13046-018-0907-z.
8
Secondary carbamate linker can facilitate the sustained release of dopamine from brain-targeted prodrug.二级氨基甲酸酯连接基可促进多巴胺从脑靶向前药的持续释放。
Bioorg Med Chem Lett. 2018 Sep 15;28(17):2856-2860. doi: 10.1016/j.bmcl.2018.07.030. Epub 2018 Jul 18.
9
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).重新评估 L 型氨基酸转运体(LAT1)的底物特异性。
J Med Chem. 2018 Aug 23;61(16):7358-7373. doi: 10.1021/acs.jmedchem.8b01007. Epub 2018 Aug 10.
10
SAR-Guided Scoring Function and Mutational Validation Reveal the Binding Mode of CGS-8216 at the α1+/γ2- Benzodiazepine Site.SAR 引导的评分函数和突变验证揭示 CGS-8216 在 α1+/γ2-苯二氮䓬位点的结合模式。
J Chem Inf Model. 2018 Aug 27;58(8):1682-1696. doi: 10.1021/acs.jcim.8b00199. Epub 2018 Aug 8.